Astrazeneca AZN
NYSE AZN
$163.66 +3.49 (+2.18%)
As of: Sep 14, 2026 · 3:07 PM EDT

Astrazeneca (AZN) Cash & Equivalents Growth (1y) (2010 - 2026)

Analysis

Astrazeneca (AZN) Cash & Equivalents Growth (1y) (2010 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash & Equiv. Growth (1y) (Qtr)
1 Asml Holding 618.04 Bn 602.06 Bn 5.90 Bn 13.95%
2 Hsbc Holdings 362.64 Bn 362.64 Bn - -
3 General Electric 329.87 Bn 320.52 Bn 6.95 Bn -13.96%
4 Astrazeneca 253.67 Bn 248.39 Bn 12.86 Bn -30.67%
5 Citigroup 228.64 Bn -2,073.66 Bn 24.75 Bn -
6 Bhp 216.08 Bn 197.54 Bn - 55.81%
7 Rio Tinto 203.71 Bn 199.33 Bn - -1.13%
8 Diageo 197.09 Bn 195.06 Bn - -30.91%
9 Unilever 139.34 Bn 132.31 Bn - 11.72%
10 Hdfc Bank 117.87 Bn 80.72 Bn - -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -30.67%
Mar 31, 2026 44.55%
Dec 31, 2025 4.06%
Sep 30, 2025 69.75%
Jun 30, 2025 2.05%
Mar 31, 2025 -33.30%
Dec 31, 2024 -6.03%
Sep 30, 2024 -1.52%
Jun 30, 2024 22.10%
Mar 31, 2024 25.82%
Dec 31, 2023 -5.29%
Sep 30, 2023 9.26%
Jun 30, 2023 17.58%
Mar 31, 2023 8.16%
Dec 31, 2022 -2.58%
Sep 30, 2022 -36.92%
Jun 30, 2022 -69.06%
Mar 31, 2022 -24.54%
Dec 31, 2021 -19.19%
Sep 30, 2021 -12.45%